Biotech SF
San Francisco Bay Area biotech stories.
Friday, September 28, 2012
Allopartis subsists on seed cash, Mission Bay incubator space
Allopartis CEO Robert Blazej.
Allopartis Biotechnologies is not unlike the other 25 or so companies that have set up shop in the Mission Bay Innovation Center: It is a startup with eager leadership, intriguing science and a penchant for saving a few dollars here, a few dollars there.
What it does not have — again like many others in the life sciences incubator space overseen by biotech company
FibroGen Inc.
— is a solid path carrying its find-a-better-enzyme technology to the market. Not that the five-person team led by
Robert Blazej
, Allopartis’s co-founder and president, isn’t trying. In fact, on its way toward discovering better enzymes to more efficiently turn cellulose into energy, the four-year-old company decided to focus on higher-margin biochemicals. The company is waiting for partnerships to come through after “several” pilot-type collaborations with large companies, Blazej said.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment